Serina Therapeutics, Inc. financial statements
Serina Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 130K | 10-K |
| Net income | −USD 19.18M | 10-K |
| Cash and equivalents | USD 3.06M | 10-Q |
| Total debt | USD 196K | EODHD |
Serina Therapeutics, Inc. financials on 6ix · Serina Therapeutics, Inc. on 6ix